In a news article from Reuters (2015)- GSK CEO, Andrew Witty, discusses the multi-billion dollar market of smoking cessation therapy. E-cigarettes are making big bucks for manufacturers, however Witty claims that GSK won’t be entering the electronic cigarette market any time soon because:
“…Witty said e-cigarettes were “just too controversial” for GSK to want to get involved in at this stage, adding that “there’s not enough data,” to provide robust evidence of the products’ risks and benefits….” (see full article here)
If only Witty and GSK had thought the same before unleashing the horrible Seroxat (drug) on to the anti-depressant consumer market?
I have yet to see ‘robust’ evidence that the benefits of Seroxat (Paxil) outweigh the risks.
For a drug like GSK’s Seroxat (dogged with controversy and scandal) Witty’s claims about e-cigarettes being ‘too controversial’ are extremely ironic…
Where’s the ‘data’ on Seroxat, Witty?..
Where’s the data proving its robust safety and effectiveness?